Dr. Truong is the Chair and Professor of Radiation Oncology at BUSM and Chief of Radiation Oncology at Boston Medical Center. She received her medical degree from the University of New South Wales, Sydney Australia and completed her residency in Radiation Oncology at New York University Medical Center, her last year as chief resident. She is board certified in Radiation Oncology by the American Board of Radiology. Her specialties include the treatment of head and neck, skin and central nervous system malignancies, as well as benign diseases, including Airway Amyloidosis. Dr. Truong serves on a number of national committees including the Scientific Committee of the American Society for Therapeutic Radiation Oncology (ASTRO), on the head and neck and skin examination committee of the American Board of Radiology (ABR), and currently serves in NRG Oncology (National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)) as the Quality of Life Head and Neck Liaison. She is the Quality of Life Co-Chair on several international head and neck cancer multicenter trials conducted by the NRG Oncology group. She contributes her radiation expertise to the National Cancer Institute’s Adult Oncology Treatment editorial board. She also leads the Cyberknife Radiosurgery program for head and neck malignancies and brain tumors. She is actively involved in promoting clinical research activities at Boston Medical Center, and was awarded funding as Principal Investigator for an American Cancer Society/Boston University Institutional Grant for the investigation of novel function imaging in head and neck cancer using CT perfusion Imaging in Patients with Head and Neck Cancer undergoing Conformal Radiotherapy. Dr. Truong has also contributed to several Boston Medical Center funded research efforts including two U.S. Army Medical Research and Material Command Office Center of Excellence Program Projects and was a project principal investigator of a department of defense funded study investigating the role of stereotactic body radiotherapy for recurrent head and neck cancer.
- Chair, Radiation Oncology, Boston University School of Medicine
- Member, BU-BMC Cancer Center, Boston University
- Member, Amyloidosis Center, Boston University
- Chief, Radiation Oncology, Boston Medical Center
- VA Boston Healthcare System
- University of New South Wales, MBBS
- University of New South Wales, BSc
- Published on 11/14/2021
Matthews BJ, Qureshi MM, Fiascone SJ, Nitschmann CC, Oladeru OT, Truong MT, Hirsch AE, Mak KS, Dyer MA. Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer. Gynecol Oncol. 2022 Jan; 164(1):27-33. PMID: 34785030.
- Published on 9/24/2021
Huang D, Qureshi MM, Sarfaty S, Truong MT, Dyer MA, Mak KS, Hirsch AE. Longitudinal Outcomes of Medical Student Research Mentorship: a 15-Year Analysis of the Radiation Oncology Mentorship Initiative. J Cancer Educ. 2021 Sep 24. PMID: 34558038.
- Published on 8/6/2021
Fujima N, Andreu-Arasa VC, Meibom SK, Mercier GA, Truong MT, Hirata K, Yasuda K, Kano S, Homma A, Kudo K, Sakai O. Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images. BMC Cancer. 2021 Aug 06; 21(1):900. PMID: 34362317.
- Published on 3/1/2021
Shah NK, Qureshi MM, Dyer MA, Truong MT, Mak KS. Optimal Radiotherapy Dose in Anal Cancer: Trends in Prescription Dose and Association with Survival. J Gastrointest Cancer. 2021 Mar; 52(1):229-236. PMID: 32152823.
- Published on 2/8/2021
Qureshi MM, Oladeru OT, Lam CM, Dyer MA, Mak KS, Hirsch AE, Truong MT. Disparities in Laryngeal Cancer Treatment and Outcomes: An Analysis by Hospital Safety-Net Burden. Laryngoscope. 2021 06; 131(6):E1987-E1997. PMID: 33555062.
- Published on 1/28/2021
Yom SS, Torres-Saavedra P, Caudell JJ, Waldron JN, Gillison ML, Xia P, Truong MT, Kong C, Jordan R, Subramaniam RM, Yao M, Chung CH, Geiger JL, Chan JW, O'Sullivan B, Blakaj DM, Mell LK, Thorstad WL, Jones CU, Banerjee RN, Lominska C, Le QT. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002). J Clin Oncol. 2021 03 20; 39(9):956-965. PMID: 33507809.
- Published on 1/12/2021
Park JJ, Qureshi MM, Lam CM, Faden DL, Truong MT. A national cancer database analysis on stereotactic body radiation therapy of head and neck cancers. Am J Otolaryngol. 2021 May-Jun; 42(3):102913. PMID: 33460976.
- Published on 1/5/2021
Wulu JA, Finlay SW, Truong MT, Ezzat WH. Immediate Postoperative Radiation Therapy after Free Tissue Transfer for Keloid Treatment. Laryngoscope. 2021 06; 131(6):E1818-E1820. PMID: 33399217.
- Published on 10/23/2020
Margalit DN, Sacco AG, Cooper JS, Ridge JA, Bakst RL, Beadle BM, Beitler JJ, Chang SS, Chen AM, Galloway TJ, Koyfman SA, Mita C, Robbins JR, Tsai CJ, Truong MT, Yom SS, Siddiqui F. Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria. Head Neck. 2021 01; 43(1):367-391. PMID: 33098180.
- Published on 10/17/2020
Tsai CJ, Galloway TJ, Margalit DN, Bakst RL, Beadle BM, Beitler JJ, Chang S, Chen A, Cooper J, Koyfman SA, Ridge JA, Robbins J, Truong MT, Yom SS, Siddiqui F. Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary. Head Neck. 2021 01; 43(1):392-406. PMID: 33068064.
View 81 more publications: View full profile at BUMC